Nurofen Comprimés Fondants (Ibuprofen)

Ibuprofen works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the synthesis of prostaglandins. Lower prostaglandin levels diminish inflammation, lower the hypothalamic set‑point for temperature, and decrease the transmission of pain signals.

The appropriate dose of Nurofen Comprimés Fondants is determined by a prescriber based on the patient’s age, weight, clinical condition, and other medications. Patients should follow the specific instructions provided by their healthcare professional.

Safety of ibuprofen in pregnancy or while breastfeeding depends on the trimester and individual risk factors. It is generally advised to avoid ibuprofen during the third trimester and to consult a healthcare professional before use during any stage of pregnancy or lactation.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibuprofen and acetaminophen both relieve pain and fever, but ibuprofen also possesses anti‑inflammatory properties due to COX inhibition. Acetaminophen lacks significant anti‑inflammatory activity and has a different safety profile, especially regarding gastrointestinal and renal effects.

Store the melt‑in‑the‑mouth tablets at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and ensure they are out of reach of children.

The tablets are designed to dissolve on the tongue without water. The patient should place the tablet in the mouth and allow it to melt completely before swallowing any residual material.

Serious risks include gastrointestinal bleeding, ulceration, severe allergic reactions such as anaphylaxis, and potential kidney or liver injury. Patients with pre‑existing cardiovascular, renal, or gastrointestinal disease should be monitored closely.

Individuals with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal bleeding or ulcer disease, severe heart failure, uncontrolled hypertension, or those in the third trimester of pregnancy should avoid ibuprofen unless directed by a healthcare professional.